 | Up a level |
Jump to: 2020
Number of items: 1.
2020
Rosenkranz, S., Channick, R., Chin, K., Jenner, B., Gaine, S., Galie, N., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V, Preiss, R., Rubin, L., Simonneau, G., Sitbon, O., Tapson, V and Lang, I (2020). Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities. Pneumologie, 74. S. S62 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790